Procedures, process and testing designed to prevent microbial contamination of the drug product purporting to be sterile are not established.
See every finding in this document View the regulator's official sourceBy Country
Ireland manufacturing-site findings
at manufacturing sites in this country 26 findings drawn from 7 published documents. The most recent cases are below; the full set is in search.
See all Ireland findingsWhich agency cited it
Companies with the most findings
Recent findings
The “systems in support of ®®drug product manufacture are not adequately maintained.
See every finding in this document View the regulator's official sourceEquipment used in the QC Microbiological Lab is not adequately maintained.
See every finding in this document View the regulator's official sourceA standard operating procedure was not followed.
See every finding in this document View the regulator's official sourceThere is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been already distributed.
See every finding in this document View the regulator's official sourceAseptic processing areas are deficient regarding the system for monitoring environmental conditions.
See every finding in this document View the regulator's official sourceOther countries
A record as of publication. Check the agency's own announcements for any later corrective action. Counts as of 2026-11-14.